In our previous studies, we showed that SIRT1 activation could ameliorate MD in hepatocytes [22], vascular smooth muscle cells [23], small intestine epithelial cells, and RTECs [17] in a severe hemorrhagic shock rat model, consistent with reports of the beneficial effects of SIRT1 in ischemic conditions. This evidence concerns the gene SIRT1 and Menkes disease.